Effects of Zinc Supplementation on Antioxidant Status and Lipid Peroxidation in Hemodialysis Patients

Journal of Renal Nutrition

Volumn 23, Issue 3, 2013, Pages 180-184

  Mazani, Mohammad ^a   Argani, Hassan ^b   Rashtchizadeh, Nadereh ^c   Ghorbanihaghjo, Amir ^c   Hamdi, Amir ^d   Asghari Estiar, Mehrdad ^e   Nezami, Nariman ^f  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; ZINC;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANTIOXIDANTS; BODY MASS INDEX; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; SPECTROPHOTOMETRY, ATOMIC; SUPEROXIDE DISMUTASE; ZINC;

EID: 84876734356     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2012.08.012     Document Type: Article

References (35)

1. Yanagisawa H. Zinc deficiency and clinical practice-validity of zinc preparations. Yakugaku Zasshi 2008, 128:333-339.
2. Maret W., Sandstead H.H. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 2006, 20:3-18.
3. Bozalioglu S., Ozkan Y., Turan M., Simsek B. Prevalence of zinc deficiency and immune response in short-term hemodialysis. J Trace Elem Med Biol 2005, 18:243-249.
4. Navarro-Alarcon M., Reyes-Perez A., Lopez-Garcia H., Palomares-Bayo M., Olalla-Herrera M., Lopez-Martinez M.C. Longitudinal study of serum zinc and copper levels in hemodialysis patients and their relation to biochemical markers. Biol Trace Elem Res 2006, 113:209-222.
5. Chevalier C.A., Liepa G., Murphy M.D., et al. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. J Ren Nutr 2002, 12:183-189.
6. Sprenger K.B., Bundschu D., Lewis K., Spohn B., Schmitz J., Franz H.E. Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study. Kidney Int Suppl 1983, 16:S315-S318.
7. Antoniou L.D., Shalhoub R.J. Zinc-induced enhancement of lymphocyte function and viability in chronic uremia. Nephron 1985, 40:14-21.
8. Xiang Y., Yang X., Bian J., Wang L. Effects of high level Zn intake on metabolism in man. Wei Sheng Yan Jiu 2004, 33:727-731.
9. Wratten M.L., Tetta C., Ursini F., Sevanian A. Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int Suppl 2000, 76:S126-S132.
10. Singh D., Kaur R., Chander V., Chopra K. Antioxidants in the prevention of renal disease. J Med Food 2006, 9:443-450.
11. Ozden M., Maral H., Akaydin D., Cetinalp P., Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002, 35:269-273.
12. Siems W., Quast S., Carluccio F., et al. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 2002, 58(Suppl 1):S12-S19.
13. Powell S.R. The antioxidant properties of zinc. J Nutr 2000, 130(5S Suppl):1447S-1454S.
14. Wratten M.L., Galaris D., Tetta C., Sevanian A. Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Antioxid Redox Signal 2002, 4:935-944.
15. Ivanovski O., Nikolov I.G., Drueke B.T., Massy A.Z. Atherosclerosis and vascular calcification in uraemia-a new experimental model. Prilozi 2007, 28:11-24.
16. Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Reference values for serum zinc concentration and prevalence of zinc deficiency in adult Iranian subjects. [published online ahead of print May 17 2012] Biol Trace Elem Res. Available at: Accessed October 22, 2012. http://www.springerlink.com/content/4r774236u51118h6/?MUD=MP.
17. Roozbeh J., Hedayati P., Sagheb M.M., et al. Effect of zinc supplementation on triglyceride, cholesterol, LDL, and HDL levels in zinc-deficient hemodialysis patients. Ren Failure 2009, 31:798-801.
18. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-500.
19. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976, 15:212-216.
20. Roussel A.M., Kerkeni A., Zouari N., Mahjoub S., Matheau J.M., Anderson R.A. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 2003, 22:316-321.
21. Fukushima T., Horike H., Fujiki S., Kitada S., Sasaki T., Kashihara N. Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients. Ther Apheresis Dial 2009, 13:213-219.
22. Wang N.P., Lim P.S., Chen T.T., Thien L.M., Wang T.H., Hsu W.M. Smoking is associated with alterations of blood thiol-group related antioxidants in patients on hemodialysis. Nephron 2002, 92:772-779.
23. Shaheen A.A., el-Fattah A.A. Effect of dietary zinc on lipid peroxidation, glutathione, protein thiols levels and superoxide dismutase activity in rat tissues. Int J Biochem Cell Biol 1995, 27:89-95.
24. Dursun E., Dursun B., Suleymanlar G., Ozben T. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus. Acta Diabetol 2005, 42:123-128.
25. Usberti M., Gerardi G.M., Gazzotti R.M., et al. Oxidative stress and cardiovascular disease in dialyzed patients. Nephron 2002, 91:25-33.
26. Ozturk O., Gumuslu S. Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age. Exp Gerontol 2004, 39:211-216.
27. Dimitrova A.A., Strashimirov D.S., Russeva A.L., Andreeva-Gateva P.A., Lakova E.T., Tzachev K.N. Effect of zinc on the activity of Cu/Zn superoxide dismutase and lipid profile in Wistar rats. Folia Med 2005, 47:42-46.
28. Pawlak K., Pawlak D., Mysliwiec M. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem 2005, 38:700-705.
29. Ceballos-Picot I., Witko-Sarsat V., Merad-Boudia M., et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 1996, 21:845-853.
30. Sidhu P., Garg M.L., Dhawan D.K. Protective effects of zinc on oxidative stress enzymes in liver of protein-deficient rats. Drug Chem Toxicol 2005, 28:211-230.
31. Maret W. The function of zinc metallothionein: A link between cellular zinc and redox state. J Nutr 2000, 130(5S Suppl):1455S-1458S.
32. Alscher D.M., Braun N., Biegger D., et al. Induction of metallothionein in proximal tubular cells by zinc and its potential as an endogenous antioxidant. Kidney Blood Press Res 2005, 28:127-133.
33. Chung M.J., Walker P.A., Brown R.W., Hogstrand C. Zinc-mediated gene expression offers protection against H2O2-induced cytotoxicity. Toxicol Appl Pharmacol 2005, 205:225-236.
34. Kojima-Yuasa A., Umeda K., Ohkita T., Opare Kennedy D., Nishiguchi S., Matsui-Yuasa I. Role of reactive oxygen species in zinc deficiency-induced hepatic stellate cell activation. Free Rad Biol Med 2005, 39:631-640.
35. Komindr S., Thirawitayakom J., Taechangam S., Puchaiwatananon O., Songchisomboon S., Domrongkitchaiporn S. Nutritional status in chronic hemodialysis patients. Biomed Environ Sci 1996, 9:256-262.